Safety and Preliminary Efficacy in Patients with Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel in Transcend NHL 001

被引：54
|
作者：
Palomba, Maria Lia
Gordon, Leo I.
Siddiqi, Tanya
Abramson, Jeremy S.
Kamdar, Manali
Lunning, Matthew A.
Maloney, David G.
Andreadis, Charalambos
Arnason, Jon E.
Ghosh, Nilanjan
Mehta, Amitkumar
Solomon, Scott R.
Farazi, Thalia
Garcia, Jacob
Dehner, Christine
Ogasawara, Ken
Gao, Jie
Wang, Michael
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136158
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Outpatient Treatment with Lisocabtagene Maraleucel in 3 Clinical Studies of Relapsed/Refractory Large B-Cell NHL, Including Second-Line Transplant Noneligible Patients: Transcend NHL 001, Outreach, and PILOT
    Bachier, Carlos
    Palomba, M. Lia
    Abramson, Jeremy
    Andreadis, Charalambos
    Sehgal, Alison
    Godwin, John
    Hildebrandt, Gerhard
    Siddiqi, Tanya
    Stevens, Don
    Farazi, Thalia
    Kostic, Ana
    Trede, Nikolaus
    Wang, Lei
    Lymp, James
    Thelen, Tennille
    Ogasawara, Ken
    Maloney, David
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 47 - 48
  • [22] Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
    Siddiqi, Tanya
    Soumerai, Jacob D.
    Dorritie, Kathleen A.
    Stephens, Deborah M.
    Riedell, Peter A.
    Arnason, Jon
    Kipps, Thomas J.
    Gillenwater, Heidi H.
    Gong, Lucy
    Yang, Lin
    Ogasawara, Ken
    Thorpe, Jerill
    Wierda, William G.
    BLOOD, 2022, 139 (12) : 1794 - 1806
  • [23] LISOCABTAGENE MARALEUCEL FOR RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: FEASIBILITY, SAFETY AND EFFICACY IN A REAL-WORLD SETTING
    Portuguese, Andrew
    Liang, Emily
    Albittar, Aya
    Hirayama, Alexandre
    Till, Brian
    Cassaday, Ryan
    Lynch, Ryan
    Poh, Christina
    Milano, Filippo
    Chapuis, Aude
    Kiem, Hans-Peter
    Maloney, David G.
    Gauthier, Jordan
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 207 - 208
  • [24] Cytokine release syndrome and neurological event costs in lisocabtagene maraleucel-treated patients in the TRANSCEND NHL 001 trial
    Abramson, Jeremy S.
    Siddiqi, Tanya
    Garcia, Jacob
    Dehner, Christine
    Kim, Yeonhee
    Nguyen, Andy
    Snyder, Sophie
    McGarvey, November
    Gitlin, Matthew
    Pelletier, Corey
    Jun, Monika P.
    BLOOD ADVANCES, 2021, 5 (06) : 1695 - 1705
  • [25] Impact of Lisocabtagene Maraleucel (liso-cel) Treatment on Health-Related Quality of Life and Health Utility in Patients (pts) with Relapsed/Refractory (R/R) Aggressive B Cell Non-Hodgkin Lymphoma (NHL): Transcend NHL 001
    Patrick, Donald L.
    Powers, Annette
    Parisi, Monika
    Kim, Yeonhee
    Garcia, Jacob
    Dehner, Christine
    Maloney, David G.
    BLOOD, 2019, 134
  • [26] Lisocabtagene Maraleucel Approved for Use in Relapsed/Refractory Large B-Cell Lymphoma
    Schuyler, Devon
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 175 - 175
  • [27] Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
    Maruyama, Dai
    Nagai, Hirokazu
    Fukuhara, Noriko
    Kitano, Toshiyuki
    Ishikawa, Takayuki
    Shibayama, Hirohiko
    Choi, Ilseung
    Hatake, Kiyohiko
    Uchida, Toshiki
    Nishikori, Momoko
    Kinoshita, Tomohiro
    Matsuno, Yoshihiro
    Nishikawa, Tomoaki
    Takahara, Satoko
    Tobinai, Kensei
    CANCER SCIENCE, 2016, 107 (12) : 1785 - 1790
  • [28] TRANSCEND NHL 001: Health-related quality of life (HRQL) and symptom (Sx) impact in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) receiving lisocabtagene maraleucel (Liso-cel; JCAR017).
    Patrick, Donald L.
    Chung, Karen C.
    Kim, Yeonhee
    Garcia, Jacob
    Dehner, Christine
    Maloney, David G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [30] Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT
    Bachier, Carlos R.
    Palomba, Maria Lia
    Abramson, Jeremy S.
    Andreadis, Charalambos
    Sehgal, Alison R.
    Godwin, John
    Hildebrandt, Gerhard C.
    Siddiqi, Tanya
    Stevens, Don
    Farazi, Thalia
    Kostic, Ana
    Trede, Nikolaus S.
    Wang, Lei
    Lymp, James
    Thelen, Tennille
    Ogasawara, Ken
    Maloney, David G.
    BLOOD, 2019, 134
12345